BioMedWire Editorial Coverage: Cancer research is entering one of its most dynamic periods in decades. The class of drugs known…
BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) robs people of control over their own bodies — slowly, relentlessly and without a…
Aggressive repurchase of its own stock by Earth Science Tech, a growing holding company focused on various aspects of the…
Last year, Congress passed changes to Medicaid eligibility requirements and CMS was given a deadline to issue final rules on those work…
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. The platform is designed to detect…
Cardiovascular disease remains one of the most expensive health conditions in the United States. Cardio Diagnostics announced plans to participate…
The FIFA World Cup started on June 11 and will end on July 19. 48 national teams are taking part,…
A study conducted by a team at Mass General Brigham has found that people with a history of traumatic brain…
Earth Science Tech, a growing holding company focused on various aspects of the healthcare industry, reported a series of operational…
CAR-T therapy has been transformational in treating many blood cancers, such as leukemia and lymphoma. However, this treatment approach hasn’t worked for…